PREVIEW MODE — Test page · Not connected to live forms
TRT Bangkok
Dr. Kenika consulting international patient about Zepbound tirzepatide program
Authentic Eli Lilly · Obesity Indication

Zepbound Thailand

Authentic Zepbound from Eli Lilly — FDA-approved Tirzepatide for chronic weight management. Cold-chain delivery across Thailand. International patients travel to our Pattaya clinic; Singapore monthly courier.

  • US FDA-approved · November 2023 · Chronic Weight Management
  • 20.9% average body-weight reduction (SURMOUNT-1, 15 mg, 72 weeks)
  • Verifiable batch numbers · Pre-filled pen · 2.5-15 mg
Dr. Kenika consulting on Zepbound tirzepatide for obesity
Dr. Kenika, Medical Director
Medical Council of Thailand · Personal supervision
Authentic
Eli Lilly KwikPen®
Doctor-Led
Dr. Kenika · MD
Trusted
Verified 5.0
Cold-Chain
Pharmacy-Grade Delivery
Body-weight reduction · SURMOUNT-1 trial
20.9%
Mean body-weight reduction in the SURMOUNT-1 trial at 72 weeks on Zepbound (tirzepatide) 15 mg.
Jastreboff et al., NEJM 2022 · n=2,539 non-diabetic adults
What that means for you

That's 17.8 kg — you'd weigh 67.2 kg.

Based on the 20.9% trial-mean. Individual outcomes vary.
Dr. Kenika explaining personalized GLP-1 weight-loss treatment plan on tablet during consultation at TRT Bangkok Dr. Kenika explaining Zepbound titration schedule Zepbound consultation room at TRT Bangkok Authentic Eli Lilly Zepbound consultation at TRT Bangkok

Licensed medical facility · Real photos · Dr. Kenika

Authenticity

Authentic Eli Lilly Zepbound — Verifiable

Counterfeit GLP-1 medicines are a real problem in unregulated channels. Zepbound at TRT Bangkok ships through pharmacy distribution with every pen traceable back to Eli Lilly.

Eli Lilly Manufacturer Markings

Every pen carries the Eli Lilly logo, the brand name "Zepbound", lot number, NDC code, and expiration date — identical to pens dispensed in US pharmacies. We do not unbox or relabel.

Cold-Chain Pharmacy Distribution

Refrigerated from Eli Lilly warehouse to our pharmacy to your hands. Temperature monitored on every shipment. No grey-market re-export.

First Injection Under Medical Supervision

Your first dose is administered by Dr. Kenika or our nurse — in clinic in Pattaya, at your hotel in Bangkok, or via guided video for remote patients. You inspect the pen markings before injection.

Documented Sourcing

Every patient receives the lot number and expiration date of their pen on the prescription record. You can cross-check against Eli Lilly's batch documentation on request.

FDA Indication

Zepbound is the Obesity-Indication Brand

Zepbound is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) plus at least one weight-related comorbidity (such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease)[1]. The molecule — Tirzepatide — is the same one marketed under the Mounjaro brand for Type 2 diabetes.

How Zepbound Works

Dual GIP + GLP-1 Agonist

Zepbound activates two gut-hormone receptors simultaneously. GLP-1 slows gastric emptying and suppresses appetite; GIP enhances fat metabolism. The dual mechanism produces substantially stronger weight reduction than GLP-1-only medicines.

Read more on our Tirzepatide Thailand page.

Zepbound vs Mounjaro

Same Molecule, Different Label

Zepbound: Obesity / chronic weight management (FDA-approved November 2023)[3]. Mounjaro: Type 2 diabetes (FDA-approved May 2022)[5]. Both contain Tirzepatide manufactured by Eli Lilly. Same pen format, same dose strengths, same titration schedule.

See the diabetes brand on our Mounjaro Thailand page.

Program Investment

Authentic Zepbound Program

Doctor-led · Authentic Eli Lilly · Cold-Chain

from 2,190 ฿ per shot

↑ Take-home pens available from 16,990 ฿/month

Every program includes
Doctor consultation
Individualized dose plan
Ongoing monitoring
Cold-chain delivery

Zepbound (tirzepatide) is FDA-approved for chronic weight management. Pharmacologically identical to Mounjaro — same Eli Lilly molecule, indication-specific labeling.

See full take-home pen options (16,990 ฿ — 36,990 ฿)
2.5 mg pen
16,990 ฿
Titration starter · weeks 1-4
5 mg pen
19,990 ฿
Therapeutic · weeks 5-8
7.5 mg pen
26,990 ฿
Up-titration · weeks 9-12
10 mg pen
32,990 ฿
Common maintenance · weeks 13-16
12.5 / 15 mg pen
36,990 ฿
Maximum maintenance · weeks 17+

Per-shot pricing at higher doses confirmed during your consultation. Final program pricing depends on your dose plan and treatment duration. Thai pharmacy advertising regulations preclude binding online prices — your exact figure is shared in private medical review.

Your Personalized Trajectory

See your expected trajectory on Zepbound.

Trajectory based on the SURMOUNT-1 clinical-trial mean. Your individualized program is confirmed in consultation — this is an evidence-based estimate, not a guarantee.

kg
Zepbound

Your trajectory · based on SURMOUNT-1 mean (Zepbound)

Weeks to goal
Projected loss
Monthly investment
from 2,190 ฿/shot

Estimator uses peer-reviewed clinical-trial mean data. Individual outcomes vary based on adherence, baseline BMI, comorbidities, and lifestyle factors. Final program plan determined in private medical consultation.[ref]

Eli Lilly Titration

Standard Zepbound Dose-Escalation

Zepbound follows the Eli Lilly prescribing-information titration. Incremental dose increases minimize GI side effects and allow your body to adapt to the appetite-suppressing effect.

View full titration schedule
Weeks 1-4
2.5 mg weekly
Adaptation phase — not yet a therapeutic dose for weight loss.
Weeks 5-8
5 mg weekly
First therapeutic dose. Many patients see meaningful weight loss from here.
Weeks 9-12
7.5 mg weekly
Up-titration if tolerated. Dr. Kenika reviews tolerance and response.
Weeks 13-16
10 mg weekly
Intermediate maintenance. Many patients hold here long-term.
Weeks 17+
12.5 – 15 mg weekly
Maximum maintenance dose — used for patients pursuing the full SURMOUNT-1 efficacy[2].

Source: Eli Lilly Zepbound full prescribing information. Schedule may be adjusted individually by Dr. Kenika.

How It Works

A simple, medically supervised path to your Zepbound program.

1

Discovery Call

15-minute WhatsApp with our clinic team. Share your goals, history, and questions. No commitment.

2

Medical Evaluation

Dr. Kenika reviews your history. Labs ordered if needed. Treatment plan decided based on your specific clinical picture.

3

Start Treatment

First dose at clinic or cold-chain delivery to your address. Titration plan + side-effect support from day one.

4

Track & Adjust

Weekly check-ins during titration. Dose adjusted to your response. Sustainable maintenance plan together.

Why TRT Bangkok

Three foundations of our weight-loss program.

DOCTOR-LED CARE

Every Zepbound patient is personally supervised by Dr. Kenika — medical history review, HbA1c monitoring where relevant, dose decisions, titration adjustments. No intake-form-only approval.

100%
MANUFACTURER-DIRECT

Authentic Zepbound from Eli Lilly via cold-chain pharmacy distribution. Batch numbers and expiry dates intact. No compounded substitutes, no grey-market sourcing.

Eli Lilly
Your Doctor

Meet Your Medical Director

Dr. Kenika Norrachetdecha, MD — Medical Director at TRT Bangkok

Dr. Kenika Norrachetdecha, MD

Medical Director · TRT Bangkok

Hormone Medicine Brain Health Metabolic Optimisation Weight Loss

Dr. Kenika Norrachetdecha, MD, leads TRT Bangkok's clinical practice. She specialises in hormone optimisation, regenerative medicine, and metabolic health, with advanced training under Dr. Mark Gordon (USA) in neuroregenerative protocols. Every Zepbound patient is personally supervised by Dr. Kenika — every titration step reviewed individually before escalation.

3.000+

Patients Treated

500+

IV Treatments

3.000+

TRT Treatments

1.000+

GLP-1 Treatments

Dr. Kenika with Dr. Mark Gordon

International Training

Advanced neuroregenerative medicine training under Dr. Mark Gordon (USA) — featured on The Joe Rogan Experience (4 appearances) for his work in hormones & brain health.

Dr. Kenika Norrachetdecha with Dr. Mark Gordon at HEAT Conference

With Dr. Mark Gordon (USA)

HEAT Conference — Neuroregenerative Medicine Training

Thai Medical License #72509 · Council Member #71253 — Verify ↗

Frequently Asked

Common Questions About Zepbound

Is this authentic Zepbound from Eli Lilly?
Yes. Zepbound is manufactured by Eli Lilly and Company. Each pen ships through cold-chain pharmaceutical distribution with batch numbers and expiry dates intact. You can verify manufacturer markings, lot code, and serial number directly on the pen before your first injection.
Zepbound vs Mounjaro — what is the difference?
Same active molecule (Tirzepatide) from Eli Lilly. Mounjaro is FDA-approved for Type 2 diabetes (May 2022); Zepbound is FDA-approved for chronic weight management (November 2023). Pharmacologically identical: same pen format, same dose strengths, same titration schedule. Dr. Kenika selects between them based on your clinical situation and dose availability. See Mounjaro Thailand.
How much weight will I lose on Zepbound?
In the SURMOUNT-1 obesity trial, adults on Zepbound 15 mg weekly lost an average 20.9% of body weight over 72 weeks[2]. Lower doses produce proportionally less weight loss. Individual results depend on starting BMI, adherence, and lifestyle support.
What are the side effects of Zepbound?
Most common: nausea, decreased appetite, mild GI discomfort during the first 4-8 weeks of titration. These typically diminish as your body adapts. Slow titration starting at 2.5 mg minimizes effects. Rare considerations include pancreatitis history and family history of medullary thyroid carcinoma — reviewed with Dr. Kenika before starting.
How do I store Zepbound in Thai climate?
Refrigerator 2-8°C. Room temperature (below 30°C) for up to 21 days once in use. Do not freeze, avoid direct sunlight. Never leave the pen on a car dashboard, balcony, or near windows in Thai climate. Our nurse demonstrates correct storage during your first injection.
How does Zepbound pricing compare to the US, UK, Australia?
Thailand pricing for authentic Eli Lilly Zepbound is meaningfully below US cash-pay rates (Eli Lilly LillyDirect lists Zepbound from approximately USD 349-549/month at certain doses) and competitive with UK and Australian private-pay markets. Exact figures depend on dose, duration, and shipping — full breakdown during consultation. For international shipping see international patients.
Can I switch from Wegovy to Zepbound?
Yes — one of the most common transitions Dr. Kenika manages. Zepbound adds GIP-receptor activity to the GLP-1 mechanism Wegovy uses, typically producing stronger weight loss. Most patients begin Zepbound at 2.5 mg even when transitioning from a maintenance Semaglutide dose. Read more on our Wegovy Thailand page.
Patient Reviews

What patients say

5.0 / 5
15 verified Google Reviews

Real reviews from real patients on Google Business Profile. Currently 5.0 ★ from 15 verified reviews — and growing.

[Live Google Review loading — Phase 2 integration via Google Places API]

Verified Patient
Recent

[Live Google Review loading — Phase 2 integration via Google Places API]

Verified Patient
Recent

[Live Google Review loading — Phase 2 integration via Google Places API]

Verified Patient
Recent

Read all reviews on Google Business Profile →

Ready to start Zepbound?

Request a consultation. Our clinic team responds within minutes on WhatsApp and walks you through eligibility, dose plan, sourcing verification, and the access mode that fits your location.

Dr. Kenika consulting on Zepbound tirzepatide for obesity
Medically reviewed by Dr. Kenika, Medical Director
Member, Medical Council of Thailand · Endocrinology & Metabolic Medicine
This page is reviewed for medical accuracy. Content is informational and does not substitute for individualized medical advice. Treatment decisions are made during private consultation.

Sources

FDA prescribing information, peer-reviewed clinical trials, and manufacturer documentation.

View all 5 sources
  1. U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. Initial U.S. Approval: 2023. FDA label (PDF) ↗
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038. View on NEJM ↗
  3. Eli Lilly and Company. FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management. Press release, November 8, 2023. Lilly Investor Relations ↗
  4. U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. Initial U.S. Approval: 2022. FDA label (PDF) ↗
  5. Eli Lilly and Company. FDA approves Lilly's Mounjaro (tirzepatide) injection. Press release, May 13, 2022. Lilly Investor Relations ↗

Additional clinical questions are discussed during your private consultation with Dr. Kenika.

Related Pages

GLP-1 Programs
Locations
Resources
Other Services
Request consultation
Insights Library

Further reading

TRIAL DEEP-DIVE · SAME MOLECULE
SURMOUNT-1 Explained
COMPARISON
Mounjaro vs Wegovy
FOUNDATION · MECHANISM
GLP-1 Medications Explained